MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluation of Acoustic Features of Speech for Monitoring Parkinson’s Disease Progression

M. Magee, J. Tamplin, M. Morris, C. Marigliani, F. Baker, A. Tsanas, G. Noffs, A. Vogel (Parkville, Australia)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1032

Keywords: Parkinson’s

Category: Parkinson's Disease: Pathophysiology

Objective: Examine the temporal stability (i.e., repeatability) and sensitivity (i.e., change) of acoustic features of speech in people with Parkinson’s Disease (PWP).

Background: Voice and speech impairments often occur in PWP. While there is evidence to support the utility of acoustic features of speech for early detection of Parkinson’s Disease (PD), its validity for monitoring change over the disease course still requires systematic evaluation.

Method: Speech samples were acquired from 27 individuals with a confirmed diagnosis of PD, at 3-month and 12-month periods following a baseline assessment. This included sustaining the vowel “a” for a prolonged period, reading a short passage, and delivering a brief unprepared monologue. Eighty-three acoustic features capturing speech timing, vocal intensity and phonation were extracted. Stability of each acoustic feature was assessed used Cronbach α coefficients (α≥ 0.70 deemed stable) while sensitivity was established using paired T-tests (p <0.05 deemed sensitive).

Results: Of the acoustic features investigated, 63.9% and 55.4% were stable at 3-months and 12-months respectively (α≥ 0.70). Features encompassing speech timing from the reading and monologue tasks were most stable. Conversely, 7.2% and 14.5% of acoustic features were sensitive to change at 3-months and 12-months periods (p<0.05). Acoustic features related to speech timing (pause duration and total speech time) and vocal intensity (intensity range) were most sensitive to change at both 3-month and 12-month periods. Pause duration from monologue speech negatively correlated with UPDRS total scores ((r)=-0.43, p=0.05). No other significant relationships were found between acoustic features and PD disease severity, perceptual ratings of speech or voice-rated quality of life

Conclusion: Overall, many acoustic features remained stable over time irrespective of PD disease course, however, others varied widely, indicating their inappropriateness for PD disease course monitoring. This highlights the need for more rigorous systematic evaluation of not only acoustic features of speech, but also the type of speech stimuli collected if we are to utilize speech as a reliable surrogate endpoint in monitoring PWP.

To cite this abstract in AMA style:

M. Magee, J. Tamplin, M. Morris, C. Marigliani, F. Baker, A. Tsanas, G. Noffs, A. Vogel. Evaluation of Acoustic Features of Speech for Monitoring Parkinson’s Disease Progression [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/evaluation-of-acoustic-features-of-speech-for-monitoring-parkinsons-disease-progression/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluation-of-acoustic-features-of-speech-for-monitoring-parkinsons-disease-progression/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley